Bastiano Sanna - 16 May 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
16 May 2022
Net transactions value
-$11,377
Form type
4
Filing time
18 May 2022, 16:22:39 UTC
Previous filing
06 May 2022
Next filing
03 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Sale $1,754 -7 -0.02% $250.56 41,787 16 May 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale $2,011 -8 -0.02% $251.37 41,779 16 May 2022 Direct F1, F2, F4
transaction VRTX Common Stock Sale $1,767 -7 -0.02% $252.43 41,772 16 May 2022 Direct F1, F2, F5
transaction VRTX Common Stock Sale $3,810 -15 -0.04% $253.99 41,757 16 May 2022 Direct F1, F2, F6
transaction VRTX Common Stock Sale $2,036 -8 -0.02% $254.44 41,749 16 May 2022 Direct F1, F2, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Dr. Sanna's company approved trading plan under Rule 10b5-1.
F2 Dr. Sanna undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $250.56 (range $250.00 to $250.87).
F4 Open market sales reported on this line occurred at a weighted average price of $251.37 (range $251.00 to $251.88).
F5 Open market sales reported on this line occurred at a weighted average price of $252.43 (range $252.15 to $253.07).
F6 Open market sales reported on this line occurred at a weighted average price of $253.99 (range $253.33 to $254.32).
F7 Open market sales reported on this line occurred at a weighted average price of $254.44 (range $254.35 to $254.57).